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Next Generation Sequencing (NGS), a recently evolved technology, have served a lot in the research 
and development sector of our society. This novel approach is a newbie and has critical advantages 
over the traditional Capillary Electrophoresis (CE) based Sanger Sequencing.  The advancement of 
NGS has led to numerous important discoveries, which could have been costlier and time taking in 
case of traditional CE based Sanger sequencing. NGS methods are highly parallelized enabling to 
sequence thousands to millions of molecules simultaneously. This technology results into huge 
amount of data, which need to be analysed to conclude valuable information. Specific data analysis 
algorithms are written for specific task to be performed. The algorithms in group, act as a tool in 
analysing the NGS data. Analysis of NGS data unravels important clues in quest for the treatment of 
various life-threatening diseases; improved crop varieties and other related scientific problems 
related to human welfare. In this review, an effort was made to address basic background of NGS 
technologies, possible applications, computational approaches and tools involved in NGS data 
analysis, future opportunities and challenges in the area. 
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1.   Introduction 
DNA sequencing is a method to obtain the exact order of occurrence of nucleotides in a 
DNA.  With the help of DNA sequence, researchers can illuminate genetic information 
from a biological system. Deciphering DNA sequences is necessary for almost all 
branches of life sciences and its understanding has grown exponentially in the past 
decades. The first-generation sequencing method, called Sanger sequencing, was 
developed by Edward Sanger in 1975. Since its inception, Sanger sequencing was 
considered as the gold standard for DNA sequencing for around three decades (Sanger et 
al., 1977). The first major breakthrough of first-generation sequencing was the Human 
Genome Project (HGP), 13-years long, $3 million project, completed in 2003. Due to 
inherent limitations in throughput, speed, scalability and resolution of first-generation 
Sanger sequencing approach, second-generation of sequencing method, or Next-
Generation Sequencing (NGS) has been developed to cater high demand for cheaper as 
well as faster sequencing technology. 
The NGS is fundamentally different approach to sequencing that lead to several 
ground-breaking discoveries and brought a new revolution in genomic research by 
revealing limitless insight related to genome, transcriptome and epigenome of any 
species. Hence, NGS technology has brought a new revolution in the welfare of human 
society. Principally, basic idea behind NGS is similar to capillary electrophoresis (CE) 
based Sanger sequencing, but NGS extends the idea to perform massive parallel 
sequencing, where millions of fragments of DNA from a single sample are accurately 
sequenced. The NGS enables sequencing of large stretch of DNA base pairs, producing 
hundreds of gigabases of data in a single sequential run. The NGS, also known as 
Massive Parallel Sequencing, allows the complete genome (of human) to be sequenced in 
less than a day. More recently, third generation sequencing (TGS) has evolved, however, 
it is still in its infancy (Hayden, 2009). Because of its maturity and understanding, among 
all the three sequencing generations (Fig. 1), the NGS is more widely accepted. 
Therefore, presented review primarily discusses the recent developments in NGS 
technology and related computational analysis. 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Overview of sequencing generations 
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1.1.   What does NGS offer? 
The NGS is a powerful, flexibly, indispensable and universal biological tool that infused 
several areas of biological study. Some of the promises and capabilities of NGS are as 
follows: 
 
• It provides us a much cheaper and faster alternative to traditional Sanger sequencing. 
Researchers can now sequence whole small genome in a day. More than five human 
genomes can be sequenced in a single run, generating data in less than a week, 
costing less than $5000 per genome (Illumina). 
• High-throughput sequencing (HTS) of the human genome lets us discover genes and 
regulatory pathways associated with disease (Grada &Weinbrecht, 2013). 
• Targeted sequencing of specific genes or genomic region helps in the identification 
of disease-causing mutations. It helps in the faster diagnosis, and outcome of 
disease-targeted sequencing may help in better therapeutic decision-making for 
several genetic diseases, including many cancers (Grada &Weinbrecht, 2013). 
• RNA-Seq (NGS of RNA) provides entire transcriptomic information of a sample 
without any need of previous knowledge related to genetic sequence of an organism. 
RNA-Seq provides a strong alternative approach to Microarrays for gene expression 
studies, and let the researchers visualize RNA expression in the form of sequence 
(Grada &Weinbrecht, 2013). 
• Variant study is common in medical genetic, where DNA sequence and data are 
compared with a reference sequence to catalogue the differences. These differences 
may range from single nucleotide polymorphisms (SNPs) to complex chromosomal 
rearrangement (Nekrutenko& Taylor, 2012). 
1.2.   Evolution of NGS 
The root of the development of NGS goes back to the discovery of double helix structure 
of DNA by James Watson and Francis Crick in 1953. Robert Holley was the first who 
sequenced nucleic acid during 1964-1965. In 1977, Frederick Sanger and Walter Gilbert 
developed sequencing methods for long length of DNA. For these three pioneer works, 
the Nobel Prize was given to Watson and Crick in 1962, Holley in 1968 and Sanger and 
Gilbert in 1980. 
The development of NGS took place in late 20th and early 21st century. The first 
NGS technology, known as Massively Parallel Signature Sequencing (MPSS), was 
launched by a USA based Lynx Therapeutics Company in 2000. This company was later 
taken over by Illumina – one of the big players in sequencing market. After MPSS, 454 
Life Sciences launched a similar kind of sequencing technology in 2004 that gained 6-
fold cost reduction compared to traditional Sanger sequencing. Later, Life Sciences was 
acquired by Roche Company. During 2005-2006, the 454 GS 20 Roche platform was 
launched that could produce 20 Mbp; and in 2007, this model was replaced by GS FLX 
capable of producing 100 Mbp, which was further enhanced to 400 Mbp in 2008.  The 
Roche 454 GS-FLX was upgraded to 454 GS-FLX + Titanium sequencing platform that 
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can produce over 600 Mbp and read length of up to 1000 bp. Roche also produced ‘GS 
Junior’ platform which handy and can be placed on a bench (Barba et al., 2014). 
In 2006, Genome Analyzer was released by Solexa, which was acquired by Illumina 
in 2007. Solexa sequencer was capable to sequence 1 Gbp in single run (Illumina). 
During the last five years, Illumina has developed Mi-Seq and Hi-Seq platforms. The Mi-
Seq platform can sequence up to 15 Gbp, while Hi-Seq systems achieves up to 600 Gbp. 
Hi-Seq 2500 system can sequence a human genome in a day. The first SOLiD sequencing 
system was launched in 2007, followed by SOLiD 5500w and 5500 lw in 2010. The 
recent SOLiD4 platform can sequence between 35-50 Gbp with a maximum read length 
between 35-50 bases. 
Life Technologies Ion Torrent sequencer was released in 2011 that uses sequencing-
by-synthesis and emulsion PCR. It does not use florescence, like other sequencing 
methods. This technology measures H+ ion release during base incorporation (Ion 
Torrent). Some of its models are PGM 314, PGM 316, PGM 318, PI and PII. The PII is 
launched in early 2015 with average reading length of 100 bases and sequencing capacity 
of up to 64 Gbp.  
Complete Genomics platform is unique in the NGS market which offers the NGS 
services, rather than selling instrumentation. Their focus is on human whole-genome 
resequencing. Currently, they do not offer any other applications such as exome, RNA-
Seq, ChIP-Seq, etc. Complete Genomics platform can achieve a sequencing rate of 3000 
Gbp per run with maximum reading length of 70 bases. Complete Genomics is going to 
launch its first commercial product, the Revelocity system, which have been designed to 
provide total end-to-end genomic solution (Complete Genomics). 
1.3.   NGS versus Sanger sequencing 
The traditional automated Sanger sequencing method, also called first generation 
sequencing, had led to several most important accomplishments that include completion 
of the HGP and many other animal and plant genomes. However, due to its heavy cost 
and time intensive task, in the late 20th and early 21st century, new methods (NGS) have 
been developed to replace the automated Sanger method. The major advancement offered 
by NGS is: i) capability to generate massive volume of data, ii) read more than one 
billion short reads in single run, iii) a fast and inexpensive method to get accurate 
genomic information. 
Preparation of sample for NGS are faster and straightforward in comparison to 
capillary electrophoresis (CE)-based Sanger sequencing. In NGS, it may be started 
directly from a gDNA or cDNA library. The DNA fragments are then ligated to platform-
specific oligonucleotide adapters and needs less than 1.5 hours to complete. On the other 
hand, CE-based Sanger sequencing needs genomic DNA that are fragmented and cloned 
into either bacterial or yeast artificial chromosomes (BACs/YACs). Further, each 
BAC/YAC are subcloned into a sequencing vector and transformed to appropriate 
microbial host. Before sequencing, template DNA is purified from individual colonies. 
These processes may consume days or even weeks, depending on genomic size. A 
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comparative summary for sample preparation of whole genome sequencing (WGS) and 
targeted sequence using CE-based Sanger sequencing and NGS are shown in Table 1. 
 
Table 1.Sample preparation in CE-based Sanger sequencing and NGS methods 
Applications CE-based Sanger sequencing Next-Generation Sequencing 
Whole genome 
sequencing 
Library preparation is more involved. Each 
sample must contain a single template, 
demanding purification from single 
bacterial, yeast colonies, or phage plaques 
from single PCR. 
Library preparation is more streamlined, 
i.e., sample can consist of a population of 
DNA molecules which do not need 
clonal purification 
Sample preparation is time consuming, 
taking days to weeks dependent on genome 
size.  
It is accomplished within hours, 
regardless of genome size. 
Targeted 
sequencing 
Library preparation is again more involved.  Library preparation is more streamlined.  
Suitable for sequencing amplicons and 
clone checking. 
Suitable for sequencing amplicons and 
clone checking 
This process takes days to weeks, 
depending upon the genome size.  
Completed within hours 
 
1.4.   NGS versus Microarray technology 
The measurement of mRNA expression under different experimental conditions has been 
of interest to the biologist. In the past decade, microarray technology has been 
extensively applied to simultaneously monitor gene expression on a genome-wide scale 
(Harismendy et al., 2009). In microarray technology, cDNA is hybridized on an array of 
complementary oligonucleotide probes corresponding to gene sunder study, and the 
abundance of mRNA is completed from its hybridization intensity. A detail discussion on 
microarray platforms and techniques can be found in (Allison et al., 2006; Ness, 2007) 
and analysis of microarray data can be found in (Quackenbush, 2001; Raza and Parveen, 
2012a; Raza and Parveen, 2012b; Raza and Parveen, 2013; Raza and Jaiswal, 2013; 
Raza, 2014; Raza and Hasan, 2015; Raza and Kohli, 2015; Raza,2015; Raza, 2016). 
Microarray technology has been widely used for the study of cancer genomes and 
transcriptome but some of its promises have not materialized due to limitations of 
microarray data. For instance, microarray based gene expression profiles only give a 
semi-quantitative assessment of gene expression due to nature of the probes included in 
the platform. Also, microarray technology is unable to give any information related to 
structural genomic aberrations and bases pair mutations (Reis-filho, 2009). 
The NGS has replaced the limitation of microarrays to detect poorly expressed genes. 
In 2008, Nature News published an article “The death of microarrays?’ stating that 
“High-throughput gene sequencing seems to be stealing a march on microarrays” and 
“Sequencing does put microarrays at risk in some areas of the life-sciences research 
market” (Ledford, 2008).NGS is used as a tool for the identification and analysis of DNA 
regions which interact with regulatory proteins in functional regulation of gene 
expression. It offers novel, and rapid means for genome-wide characterisation and 
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profiling of mRNAs, small RNAs, transcription factor regions, chromatin structure and 
DNA methylation patterns (Ansorge, 2009). 
1.5.   Challenges in data interpretation 
The ‘Big Data Problem’ is a pressing issue originated with social networking, life 
sciences and bioinformatics research. The real difficulty with biomedical research is lack 
of appropriate computational tool and infrastructure to carry out analysis and 
interpretation of modern vast datasets (such as NGS data). Some of the major issues with 
analysis, interpretation, reproducibility and accessibility of NGS data have been pointed 
out by Nekrutenko and Taylor (2012). Some of these issues, extracted from Nekrutenko 
and Taylor (2012), are described as follows: 
• Adoption of existing analysis practices: There must be some well-defined and 
accepted data analysis practices so that it can be adopted as common analysis 
practice. For instance, 1000 Genome Project (GPC, 2010) and HapMap (Gibbs et al., 
2003) are highly coordinated effort that defines series of accepted practices for 
‘variant discovery’. Nekrutenko and Taylor (2012) found that despite of well 
documented analytical procedure developed by 1000 Genome Project, the research 
communities are still using a mix of heterogeneous approaches for various studies. 
• Difficulty of reproducibility: Research publications would be influential, if it 
maintains complete detail on how to repeat the reported analysis so that other 
researchers can adopt similar approaches in their own research studies. Nekrutenko 
and Taylor (2012) reported that today’s publications reporting computational 
analysis lack to provide sufficient information, such as input data sets, program 
source code or scripts, all parameter settings so that computational reproducibility 
may be achieved. Similarly, NGS data analysis results cannot be accurately verified, 
reproduced, adopted or used, that creates a shocking reproducibility crisis 
(Nekrutenko&Taylor, 2012). 
• Potential of integrative resources: As described in (Nekrutenko& Taylor, 2012), 
most biological researchers face difficulties in computationally complex analysis on 
large datasets, and also computation analysis steps are not well documented. In this 
direction, a number of integrative frameworks have been developed which bring 
diverse tools together under the aegis of unified interface. Some of these frameworks 
are BioExtract (Lushbough, 2010), Galaxy (Goecks et al., 2010), GenePattern (Reich 
et al., 2006), GeneProf (Halbritter et al., 2011), Mobyle (Néron, et al., 2009) and so 
on. These potential integrative resources empower bioinformaticians and biomedical 
researchers to make use of powerful computing infrastructure, required for NGS data 
analysis.  
• Making HPC infrastructure useful to biologists: Analysing NGS data is computation 
extensive. There are several powerful high performance computing (HPC) resources 
that may be applied for NGS computation. The HPC resources may include 
computing clusters that can be distributed over different geographical regions. With 
the popularity of Cloud Computing, many vendors are now offering ‘software as a 
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service’ analysis solution for sequence data, including DNAnexusa and 
GenomeQuestb. There are some free and open-source software (FOSS) that can be 
scaled in cloud infrastructure, but these are basically single purpose. Some of the 
FOSS tools are Crossbow (Langmead et al., 2009) used for variant discovery, Myrna 
(Langmead& Hansen, 2010) for RNA-Seq analysis and CloVR (Angiuoli et al., 
2011) for metagenomic annotations.  
• Improving long-term archiving: One of the major concerns for analysis services is its 
longevity, i.e., an online analysis tool is not guaranteed to be online forever.  One 
promising solution is to archive the snapshots of a particular analysis (Nekrutenko& 
Taylor, 2012). 
1.6.   Limitations of NGS and promises of TGS 
• Although, NGS is cheaper and faster in comparison to traditional Sanger sequencing 
but still it is too expensive to be affordable by small labs or an individual.  
• NGS data analysis is time-consuming and needs sufficient knowledge of 
bioinformatics to harvest accurate information from these sequence data. 
• The National Human Genome Research Institute (NHGRI) posed an open goal to 
minimize the cost of human genome sequencing to $1000 to fuel further 
development in NGS technologies so that routine sequencing of human genomes can 
be used as a tool to diagnose various diseases. But, till date this target is still too far 
from its goal of $1000 genome (Hert et al., 2008). 
• NGS supports read lengths of small size, which results into highly repetitive 
sequences. Support for sequencing from short read lengths is one of the major 
shortcoming which limit its application, especially in de novo sequencing (Hert et 
al., 2008).  
• Data processing steps is another major bottleneck for the implementation and 
capitalization of NGS technology (Daber et al., 2013). 
Third generation sequencing (TGS) takes advantage of the above gaps of NGS 
technologies and allows direct sequencing of single molecules. Single molecule 
sequencing (SMS) technologies have the ability to sequence with longer read lengths 
keep the cost and time both lower without  compromising the quality of the genome 
assembly.   
2.   Methodology of Next Generation Sequencing 
2.1.   How the stuff works 
Basic principle on which NGS works is similar to traditional Sanger sequencing methods 
involving capillary electrophoresis. Mostly, different NGS platforms adopt their own 
specific protocol in the sequencing methods. NGS starts with template preparation, and 
                                                 
ahttp://www.dnanexus.com 
bhttp://genomequest.com/ 
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generally, the double-stranded DNA is considered as the starting material. However, the 
source from which this material is derived may vary. Sources can be either genomic 
DNA, immuno-precipitated DNA, reverse-transcribed RNA or cDNA (Rizzo et. al., 
2012). The next step involves library preparation. If genomic DNA was considered in the 
previous step, it should be fragmented into linear DNA molecules. If RNA was 
considered in the previous step by the means of reverse transcription, cDNA is obtained 
for preparation of linear DNA molecules. Moreover, the fragmentation of these DNA 
molecules into smaller fragments is involved, which along with specific size selection 
steps serve to break the considered DNA template into smaller, but sequence-able 
fragments depending upon requisite platform. Moreover, adapter ligation is also involved 
in this process, which adds platform specific, synthetic DNAs at the end of the DNA 
fragments present in this library to facilitate the sequencing reactions. Thus, sequence 
library preparation involves some common steps of fragmentation, size selection and 
adapter ligation. 
Next step involves library amplification, to produce significant signal for nucleotide 
addition. This step involves either by the attachment of DNA fragment to microbead or 
attachment of the same to glass slide, when some PCR techniques are followed. Library 
amplification eventually leads into the sequencing reaction and imaging process. 
Ultimate destiny of NGS is to analyse the data produced through this sequencing process. 
NGS data analysis is complex and crucial task. It involves assessment of some important 
and vital genes or regulatory elements in the given genome. There are several tools 
available which can be either downloaded to local machine or used on the Web for NGS 
data analysis. A short description of the workflow for NGS is depicted in the Fig 2.  
 
 
Fig. 2 How stuff works: NGS an overview 
2.2.   Major platforms in NGS 
Illumina Sequencing is one of the major platforms used in NGS. In this sequencing 
technology reads of 100-150bp are considered. Comparatively longer fragments are 
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considered from the template library for ligation using generic adaptors. Further, these 
ligated fragments are annealed (attached) to a glass slide. In the next stage, Polymerase 
Chain Reaction (PCR) is carried out, in order to amplify and make several copies of a 
read. Later, amplified copies of reads are separated into single strands, which is to be 
sequenced. Next, the slide is flooded with fluorescently labelled nucleotides (A, G, C & 
T) and DNA polymerase. Each nucleotide has a unique colour to identify itself. 
Terminator ensures that only one base is added at a time. The fluorescent signal in form 
of image is recorded, which indicates the base added. At this stage, glass slide is re-
prepared for next cycle. Terminators are removed, which allows the next base to add in 
this process. At the same time, fluorescent signal is also removed in order to prevent 
future contaminations of the signals. The process is repeated by addition of a nucleotide 
at a time and imaging process in between. Using the computers, the bases are detected at 
each site in each image, which in turn help in construction of a sequence. 
454 sequencing technology has the ability to sequence much longer reads as 
compared to Illumina. The basic principle is similar to Illumina, where the optical signals 
are read on the addition of the bases. Though 454 sequencing involves fragmentation of 
DNA or RNA too, in this case, the fragmentation results into 1kb long reads. In the 
process of library amplification, the fragments are attached to the microbeads. Using 
PCR, the fragments are amplified. Here, the wells also contain DNA polymerase and 
sequencing buffers. In the next stage, the slide is flooded with any one of the four 
nucleotide species (A, G, C, or T). Addition of each nucleotide releases an optic signal. 
The locations of signals are spotted to identify the bead where the nucleotides are added 
to. The process recycles after washing the mix. 454 sequencing generates graphs for each 
sequence read, which reflects the signal density for each nucleotide wash. Using 
computational approach, the density of signals in each wash facilitates the retrieval of the 
sequence. 
Ion Torrent PGM (Personal Genome Machine) sequencing is different from Illumina 
and 454 sequencing platforms. This sequencing platform does not uses optic signals. 
They utilize the concept that the addition of a dNTP to a DNA polymer releases an H+ 
ion. Here template DNA or RNA is fragmented into size of ~200bp. Using emulsion 
PCR, the amplification takes place. Just as in case 454 sequencing, the slide is flooded 
with single types of dNTP, along with buffers and polymerase. H+ ion released on 
addition of dNTP to a DNA polymer decreases the pH. The pH changes are detected and 
recorded from each well, which allows determining the bases type and its concentration 
in that well. 
Helicos (HeliScope Genetic Analysis System) is the first commercial NGS platform 
which used the concept of single molecule fluorescent sequencing. Single molecule 
sequencing strategy process simplifies the DNA sample preparation process and avoids 
PCR induced errors. In this process, DNA is simply trimmed into smaller fragments, 
tailed with poly A, and hybridized to a flow cell surface containing oligo-dT for 
sequencing-by-synthesis of billions of molecules in parallel (Thompson et. al., 2010). 
Requirement for less material adds a plus to this sequencing technique as compared to 
other technologies. 
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Pacific Biosciences’s SMRT is single molecule real-time sequencing technologies 
which is popular from the last few years due to its higher accuracy, suitability for small 
genome, and study of facile closure bacterial genome without any additional experiment 
(van Dijk et al., 2014). It provides considerably longer and highly accurate DNA 
sequence from single molecule and deciphers where methylated bases occur, which is 
usually not produced by other sequencing platforms (Roberts et al., 2013). The average 
reads of current Pacific Biosciences’s instrument is 10 Kbp or longer, which is almost 
100 times longer than other NGS platforms, 100 times smaller amount of gaps compared 
to NGS (Sakai et al., 2015). In several studies it has been revealed that SMRT-based 
assemblies facilitate a more comprehensive gene annotation than NGS-based assemblies 
where lots of genes are generally missed or fragmented (Sakai et al., 2015). The SMRT 
sequencing technologies are considered as third generation sequencing (TGS). Some of 
the applications of SMRT are de nova assembly of novel genomes, DNA 
methyltransferase, etc. A comparative view of different sequencing platform and their 
sequencing chemistry, template preparation, strength and weaknesses is shown in Table 
2. 
 
Table 2.A comparative reviews of various NGS and TGS platforms 
Sequencing 
methods 
Sequenci
ng 
platform 
Sequencing 
chemistry 
Template 
preparation 
Strength Limitation 
Sequence by 
synthesis 
Illumina reverse 
terminator 
solid-phase widely used; large 
throughputa; short run 
timeb 
low number of total reads b 
Pyrosequencing Roch 454 Pyrosequencing emulsion 
PCR 
longer reads; short run 
time 
reagents are costly 
Ion semiconductor Ion torrent H+ ion sensitive 
transistor 
emulsion 
PCR 
low cost; short run time low number of total reads 
Single molecule 
florescent 
sequencing 
Helicos reverse 
terminator 
single 
molecule 
free from errors occurring 
from amplification process 
not commonly used; 
company provides 
sequencing services 
Single molecule 
real-time (SMRT) 
Pacific 
Bioscienc
es 
sequence by 
synthesis 
single 
molecule 
Faster and longer read 
lengths, allows detection 
of nucleotide modification 
very expensive and needs 
huge storage and 
computation power 
3.   Application Areas 
The NGS has served in several aspects of medical and biochemical researches 
worldwide. Below we discuss some widely used applications of NGS. 
3.1.   Whole genome sequencing (WGS) 
The WGS involves sequencing of entire genome, for instance HGP is a good example of 
whole genome sequence which was completed in 2013. HGP was based on traditional 
capillary electrophoresis-base Sanger sequencing method that cost ~3 billion USD and 
was completed in more than ten years. In contrast, NGS performs massively parallel 
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sequencing which facilitates the HTS and thereby responsible for entire genome 
sequencing in less than a day at minimum cost. Human genome sequencing helps in 
identifying the specific genes and their regulatory partners involved in the pathological 
processes (Grada et. al., 2013). The WGS provides deeper understanding for genetic 
variations (impacting the normal function of a body), drug response on a gene set, and 
many other complex/simple biological processes. In the coming days, there will be more 
favourable applications of WGS for human welfare. 
3.2.   Exome sequencing 
It helps in investigating the protein coding regions within the genome. Exome shares only 
small portion of the whole genome. Exomes are gene-coding region and therefore 
important site of concern for clinicians and researchers. Mutations, i.e., alterations in this 
part of genome results are possible causes of a disease or other abnormal conditions. In 
case of human genome, exome represents less than 2% of the total genome, but contains 
nearly 85% of disease-causing variants. Therefore, sequencing this part of genome in-
spite of WGS results in the cost-effective sequencing. Important applications of exome 
sequencing involve variant association studies, discovering relevant mutations in exome 
region, identification of disease-related variations and so on. 
3.3.   Targeted resequencing 
It involves in the sequencing of genomic regions of interest. This region is generally a 
small subset of the genome, such as exome, a set of genes, a particular chromosome or a 
region of particular interest. This enables in reduced cost sequencing approach. 
Moreover, narrowing down the search region enables one to get closer variation analysis 
which could have been impossible, when considering genome analysis on broader terms. 
Targeted resequencing has been found useful in discovering the point mutations, insertion 
or deletions, gene rearrangements and variations occurring in copy number. 
3.4.   Chromatin immunoprecipitation sequencing (ChIP-Seq) 
It is used to analyse the interactions of proteins with DNA and RNA. ChIP-Seq combines 
the ChIP technique and NGS technique to identify the binding sites of the DNA 
associated proteins. This enables in interpreting the regulation events which may be 
causative to many biological processes such as gene regulation, DNA repair, and DNA 
synthesis. ChIP-Seq also serves important role in classifying the disease situations 
resulting from abnormal functioning of the genomic contents and their expression levels. 
Important applications of ChIP-Seq include analysis of epigenetic modifications, 
mapping of epigenetically modified DNA sequences, interactions of viral protein with 
human genome resulting in complex disease situations. 
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3.5.   RNA sequencing (RNA-Seq) 
RNA sequencing (RNA-Seq) is a transcriptome sequencing approach and involves a wide 
variety of applications, ranging from simple mRNA profiling to discovery of the entire 
transcriptome. RNA-Seq is being popular nowadays because they are found uncovering 
information which may have been missed by array-based platforms regardless of prior 
knowledge of the transcript sequence. Key features of RNA-Seq include: detection of 
transcripts with low expression levels, and transcript analysis with or without reference 
sequence. Moreover, RNA-Seq is found to be a powerful tool for accurate quantification 
of expression levels. 
The above list of applications of NGS is not exhaustive. There are several other 
applications directly or indirectly attached with HTS. Moreover, as stated before, NGS is 
a newbie, but with the passage of time there will be several improvements and additions 
to this technology which shall help for quality researches for human welfare. 
4.   Database Archives 
NGS platforms are producing unprecedented amount of sequence data. Some of the 
popular and commonly used NGS database archives are as follows: 
4.1.   Sequence Read Archive 
To archive large volumes of NGS data, National Centre for Biotechnology Information 
(NCBI) designed an archive to accommodate these data sets. The three partners of 
International Nucleotides Sequencing Database Collaboration (INSDC) – NCBI, 
European Bioinformatics Institute (EBI) and DNA Data Bank of Japan (DDBJ), 
established an archive, named as Sequence Read Archive (SRA), to facilitate the 
scientific community an archive for NGS data sets (Shumway et al., 2009). The SRA 
enhance the reproducibility and facilitate the researchers for new discoveries by 
comparing data sets. The SRA stores raw NGS data and alignment information from 
different platforms that includes Roche 454, Illumina Genome Anlayzer, SOLiD system 
by Applied Biosystems, Heliscope by Helicos, IonTorrent by Life Technologies and 
Complete Genomics. The SRA database is accessible from three different collaborating 
organizations – NCBIc , EBId  and DDBJe. These three SRAs are mirror databases. The 
year-wise growth of SRA database is shown in Fig. 3, showing unprecedented growth of 
data after 2011. 
                                                 
chttp://www.ncbi.nlm.nih.gov/Traces/sra/ 
dhttp://www.ebi.ac.uk/ena 
ehttp://trace.ddbj.nig.ac.jp/dra/index_e.html 
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* till May 25, 2016 
Fig. 3 Year-wise growth of number of bases and its data size for SRA database 
4.2.   RNA-Seq Atlas 
RNA-Seq Atlas (Krupp et al., 2012) is a database repository of RNA-Seq gene 
expression profiles and query tools. It provides free, easy and user-friendly access to 
RNA-Seq gene expression profiles and several tools to compare tissues as well as genes 
having specific expression patterns. To enhance its scope, RNA-Seq Atlas data are linked 
to functional and genetic databases that provides information related to corresponding 
genes using NCBI nucleotide database, gene signalling and pathway analysis using Kyoto 
Encyclopedia of Genes and Genomes (KEGG), and evaluation of gene functions using 
Gene Ontology (GO) database. 
4.3.   NGS Catalog 
Another database, called NGS Catalog, has been developed by Xia and collaborators (Xia 
et al., 2012), that collects, curates and manages NGS data taken from published articles. 
This Catalog stores publication information related to NGS studies, their mutation 
characteristics, and mutated genesand gene fusion detected. The NGS Catalog is 
accessible through http://bioinfo.mc.vanderbilt.edu/NGS/. Also, this database gives a 
comprehensive and updated software list widely applied by NGS community, and general 
pipeline for the analysis of Exom-Seq, WGS and RNA-Seq data. This catalog contains 
over 295 records – 47 RNA-Seq datasets, 194 Exome sequencing and 54 whole genome 
sequencing. 
4.4.   LANL HIV-DB Next Generation Sequence Archive 
It is a repository for next-generation lenti-virus sequence data sets containing HIV, SIV 
and anti-HIV/SIV antibody ultra-deep sequences. It can be accessed through 
http://www.hiv.lanl.gov/content/sequence/HIV/NextGenArchive/ (Archer et al., 2012). 
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4.5.   Gene Expression Omnibus 
Gene Expression Omnibus (GEOf) is a public repository that archives and freely 
distributes microarray, NGS, and other forms of high-throughput functional genomics 
data submitted by the research community. It supports MIAME-compliant Array as well 
as sequence-based data submissions. Till writing of this paper, GEO contains over 2,000 
HTS platform entries, out of total ~14,500 platforms. 
5.   Computational Analysis 
Various platforms of NGS technologies have made it possible to sequence huge amount 
of high throughput data in less time and cost. In today’s era of NGS, single laboratory is 
able to sequence the entire human genome within a week for a few thousand dollars only 
(Gullapalli et. al., 2012). Production of NGS data is followed by its analysis. Careful 
analysis of NGS data results in important knowledge discovery and conclusions. With the 
advancement of time, there are uncountable efforts from researchers in developing 
algorithm and tool for analysis of the NGS data. Different platform need different steps 
and protocol in their analysis portion. To name few, some applications are CisGenome, 
MACS, PeakSeq, QUEST, SISSRs, CNV-Seq. A complete computational analysis 
workflow of NGS, starting from data preprocessing to network reconstruction and 
analysis, to drug discovery is shown in Fig 4. In this section, we discussed the analysis of 
NGS data obtained on Illumina platform. 
                                                 
fhttp://www.ncbi.nlm.nih.gov/geo/ 
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Fig. 4. The computational workflow for drug discovery starting from raw image data obtained from NGS 
sequencing is divided into three broad steps namely NGS data processing, Network construction and analysis, 
and Drug discovery. BOX 1 representing NGS data processing. The raw image data are processed into 
sequences by base-calling algorithms. Then reads are mapped with reference genomes/transcripts with available 
databases (GOLD/ MirWalk, Rfam). As a result uniquely mapped reads, multiple mapped reads and unmapped 
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reads can be identified. Mapped reads then undergo for read quantification with help of peak-calling algorithms 
which enable to identify  alternative splicing event, protein binding site, differentially expressed genes, 
noncoding RNA, small variants in sequences and can also give insight to allele specific expression. BOX 2 
depicts Network reconstruction and analysis of DEGs and ncRNA. In this step, co-expression network is 
constructed by WGCNA method and results into some coexpressed gene modules. Then we go for enrichment 
analysis of modules to identify module hub genes by Guilt-By-Association method involving GO annotations, 
Reactome and KEGG pathways. Then go for regression modelling to identify key hub genes from module. Then 
validate them by model reconstruction. Through this step we are able to get key genes for the disease. BOX 3 
represents steps of Drug discovery. The identified genes can be subjected for respective protein identification 
(Expasy tools, etc).  This protein will act as drug target having drug binding sites. Then we move towards lead 
identification which would give us enormous library of potent ligands that could bind protein. Then we go for 
virtual screening which involves selection of few potent leads based on binding affinity, etc. The most potent 
lead candidates are then subjected for optimization in order to maximize its druggability.  Thus at last we get 
drug that can be further subjected to experimental and clinical trials. 
 
5.1.   ChIP-Seq analysis 
Chromatin immunoprecipitation (ChIP) is commonly used in determining the Protein-
DNA interactions. As discussed before, these interactions are vital in identifying the 
gene-expression profiles during cellular development and differentiation. ChIP-Seq is a 
combination of ChIP and NGS which has been widely accepted nowadays for protein-
DNA interactions on a genome-wide scale. There are series of steps involved in ChIP and 
it is a tedious and complicated process. Eventually, after PCR amplification, there is 
application of massively parallel sequencing. Increasing demand and adaptation for 
ChIP-seq to reveal transcriptional and epigenetic regulatory mechanism in experimental 
laboratories round the globe has become comprehensive and sophisticated (Shin et. al, 
2013). Below, we discuss simple approach of analysing the Illumina ChIP-Seq data, 
which helps in retrieval of useful information from the raw sequence reads. 
In the first step, the sequenced data undergoes through the Image Analysis phase and 
Base Calling phase. The Genome Analyzer facilitates the generation of actual sequence 
data from the images acquired during the sequencing of this data via synthesis chemistry. 
In the next step, there is use of ELAND, an alignment algorithm, which aligns a set of 
short sequence tags against a genome. The output of this algorithm lists all the reads of 
the given sequence with respect to their genomic coordinates. For alignment of larger 
genomes (>1Mb), alignment program ‘Eland_extended’ is used, by calling the same in 
GERALD configuration file. For alignment of smaller genomes (<1Mb), alignment 
program ‘PhagAlign’ is used in places of alignment program ‘Eland_extended’.  
Researchers view their ChIP-seq data as a peak (signal profiles) on a genome 
browser. Most of them use the University of California Santa Cruz (UCSC) genome 
browser (Ken et. al., 2002) available over www (http://genome.ucsc.edu). UCSC genome 
browser has several functions. This browser is not only a web based application with 
standard browsing capabilities, but it also has several built features/tools to provide 
genomic information, evolutionary conservation, and relevant data from NIH funded 
genomic groups like Encyclopedia of DNA elements, commonly known as ENCODE 
(Raney et. al., 2010). Using UCSC genome browser, the read data which are specifically 
aligned to a given genome are viewed as a custom track. This track can be submitted in 
either BED format or Wiggle (WIG) format. BED format is a text file, which contains 
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chromosomal start and end positions. The WIG format allows the visual examination for 
GC percent, probability scores and transcriptome data. Although, BED format provides 
better visual presentation of the data compared to the WIG format, there are limitation 
issues for file size, which can be uploaded on UCSC genome browser. The plus point in 
WIG format is its compactness, as compared to the BED format, which enables to 
examine larger dataset. Software requirement for ChIP-Seq analysis includes the 
installation of Illumina Genome Analyser Pipeline suite, which comprises of the Image 
analysis script, Base calling script and alignment script (GERALD), to align the reads 
with the reference genome. 
5.2.   RNA-Seq analysis 
RNA-Seq basically counts the number of reads that align to one of thousands of different 
cDNAs, producing results similar to gene expression of microarrays. Reads are aligned to 
an annotated reference genome, and those aligning to exon, genes and splicing junctions 
are counted. Similarity, variants (CSNPs, indel) may be counted for variant analysis. The 
final steps are data visualization and interpretation, calculating gene- and transcript- 
expression and reporting differential expression. The workflow of RNA-Seq data analysis 
is shown in Fig. 5. In the first step, the sequencing output files are produced in 
compressed FASTQ format, and serve as input for next stage of the analysis. In the next 
stage, reads are aligned to the reference genome. The reads aligning to the exons, genes 
and splice junctions are counted and normalized resulting in generation of data of 
approximately 1.3Mb. Moreover, if desired, the cSNPs, indels can also be counted. Final 
stage involves the data visualization, data interpretation for the Gene- and transcript-level 
expression and differential expression levels. Beyond gene expression analysis, RNA-Seq 
can be used for i) identifying alternative splicing events, ii) allele-specific expression and 
iii) rate and novel transcripts, and so on. 
 
 
 
 
Fig. 5. Workflow of RNA-Seq data generation and analysis (Source: Data Sheet, Illumina Sequencing) 
 
~ 3 GB 
(FASTQ 
~ 1 MB < 1 MB 
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RNA-Seq is found to be vital tool for RNA profiling, discovering, and quantifying 
the rare, novel RNA transcripts.  This sequencing technology has results similar to the 
gene expressions of the microarray data, but the informatics challenges and methods of 
analysis is different than microarray data analysis. There are two broad ways, in which 
the RNA-Seq analysis is different from microarray. In the case of RNA-Seq, the 
sequences obtained via RNA-Seq methods are generally mapped to the libraries of known 
exons from known transcripts. Moreover, RNA-Seq measures the number of distinct 
sequence reads using differential statistical tests. All these factors facilitate the RNA-Seq 
method in following unbiased step in analysis, which could have been possible from 
previous assumptions about the nature of transcriptome. This technology provides an 
advantage in investigating the species which have poor or missing genomic annotation. In 
case of microarray, the step involved in library mapping is absent and the continuous 
probe intensities are measured. Galaxy project is an academic initiative that allows RNA-
Seq alignment, counting process, producing and uploading FASTQ files, selecting from a 
limited number of alignments and counting parameters. 
There are several tools available for transcriptome data analysis too. Specifically, the 
free, open-source Tuxedo Suite comprising of Bowtie, TopHat, and Cufflinks has been 
widely used. Some of the commercial software providers for the analysing the RNA-Seq 
data are CLC Bio, GeoSpiza, GenomeQuest, and Strand Scientific Intelligence. Below 
we discuss the analysis protocol for Illumina based RNA-Seq data.Complex transcript 
data demands for highest sensitive algorithms and tools for measuring and detecting the 
changes in abundance and structure. The demand for improved throughput and costs 
requirement has enabled in development of better and sophisticated tools for RNA-Seq 
analysis. 
5.3.   Non-coding RNA (ncRNA) Analysis 
It is known that most of the genes in human genome are transcribed but only a fraction of 
them encode for proteins. The remaining transcriptome is considered as non-coding RNA 
(ncRNA). Regulatory ncRNAs affect the expression and function of protein coding genes 
(Guffanti et al., 2014). Various studies related to cancer and ncRNA have been carried 
out whose goal was to discover molecular signatures and cancer biomarkers. The 
discovery of cancer biomarkers may reveal parameters for the early detection of cancer, 
its diagnosis, prognosis and prediction of response to anticancer drugs, prediction of 
recurrence, and identification of putative drug targets. Computational analysis of ncRNA 
can be comprised of three essential tasks: i) post-sequencing data analysis pipeline for 
ncRNa detection, classification and expression analysis; ii) a data module providing 
annotation information and storage for the analysis results; iii) a visualization and query 
system to depict and perform the functional analysis of raw data, and present results 
(Veneziano et al., 2015). The ncRNAs can be grouped in to various classes, each one 
having their own 3-dimentional folding and its own specific function, which are 
described in Table 3. Among all the ncRNA classes, microRNA (miRNA), long ncRNA 
(lncRNA) and PIWI interacting RNA (piRNA) are the most studied in cancer research 
(Esteller, 2011; Jorge et al., 2012). 
Table 3. Different classes of ncRNA with their functions 
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Non-coding RNA classes Functions 
Micro RNA (miRNA) Repress gene expression 
Long non-coding RNAs (lncRNAs) Regulation of several cellular process including spigenetics, 
differentiation, proliferation and nuclear import 
Ribosomal and transport RNAs Essential for translation 
Small nucleolar RNAs (snoRNAs) Biogenesis and control of ribosome activity 
Small nuclear RNAs Promote splicing of pre-mRNAs 
Small interfering RNAs (siRNAs) Regulate cellular proliferation and apoptosis 
PIWI-Interacting RNAs (piRNAs) To inhibit transposable elements and DNA methylation in germ 
line.  
Circular RNAs (circRNAs) Untranslated, very stable, and conserved RNA molecules found in 
animals. 
The miRNAs consist of on average 22 nucleotides in length and mediate gene 
silencing by paring with specific region of mRNA to prevent its translation. The target 
genes of miRNA are mostly concerned with the fundamental cellular processes and 
aberrations in the expression of miRNAs have been rigorously studied in various cancers 
as they act as oncogenes (tumor suppressor genes) (Meiri et al., 2010). Also, recent 
studies by Matsui and colleagues (Matsui et al., 2013) suggested that miRNA may 
directly regulate transcription by interaction with the promoter region of divergently 
transcribed genes.  In a study by Lui et al. (2011), they compared the expression of 
miRNAs having gastric cancer against normal samples. Among the 20 cancerous 
samples, 19 were detected as over expressed and the miR-1, miR-20a, miR-27a, miR-34, 
and miR-423-5p were identified as potential biomarkers for the gastric cancer diagnosis. 
Similarly, Wu et al., (2012) analysed samples of 42 breast cancer patients and detected 
over 800 circulating miRNAs. One of the earliest software tools for large-scale RNA-Seq 
data analysis is miRDeep (Fridlander et al., 2008), which is a stand-alone tool that can 
detect both known and novel miRNAs. Later, miRDeep was enhanced to miRDeep* (An 
et al., 2013) which has been proved to output-perform its earlier versions. Another 
integrated tools for the prediction and analysis of various classes of small ncRNAs on 
RNA-Seq data are DARIO (Fasold et al., 2011), CPSS (Zhang et al., 2012), ncPRO-seq 
(Chen et al., 2012), RNA-CODE (Yuan and Sun, 2013). Beside prediction of miRNA, 
there are several database resources for ncRNA, but the most widely used database for 
cancer studies are: human genome hg18 assembly (Dreszer et al., 2012), miRBase 
(Kozomara and Griffiths-Jones, 2010), Rfam (Gardner et al., 2011) and microRNA.org 
(Betel et al., 2008). Similarly, miRNA target prediction tools and its databases are 
TargetScan (Lewis et al., 2003), RNA Hybrid (Rehmsmeier et al., 2004), miRDB (Wang 
and El-Naga, 2008), DIANA-microT (Maragkakis et al., 2009), TarBase (Papadopoulos 
et al., 2009), miR2Disease (Jiang et al., 2009), miRecords (Xiao et al., 2009), 
miRWalk2.0 (Dweep and Gretz, 2015). 
The lncRNAs have more than 200 nucleotides in length and most of them are still 
not fully characterized. Several studies reported alternations in different lncRNAs in 
different types of cancers (Cheng et al., 2011; Tahira et al., 2011; Yang et al., 2012).The 
lncRNAs, along with ncRNAs, have been identified as possible suspects in the 
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involvement with several neurodeneration-related processes and proteins (Guffanti et al., 
2014).One of the software pipelines for the detection of novel lncRNAs is called 
lncRScan (Sun et al,. 2013). Recently, Soreq et al., (2014) integrated full profile 
characterization of lncRNAs in the workflow of RNA-Seq analysis (Veneziano et al.., 
2015).A comprehensive database for lncRNA, known as Noncode, became available very 
recently (Xie et al., 2014). 
Unlike miRNAs and siRNAs which are broadly expressed in most of the cells and 
tissue types, the expression and functions of piRNAs are confined to germ cells and 
gonadal somantic cells (Aravin et al., 2007). The piRNAs, like other ncRNAs, has been 
found to play possible role in the biogenesis of cancer. It interacts with PIWI proteins to 
promote silencing of transposable elements and maintain the integrity of DNA. The 
circular RNAs (circRNAs), forming a covalently closed continuous loop, are 
untranslated, very stable and conserved RNA molecules in animals (Veneziano et al., 
2015).Few circRNAs have been found as potential gene regulators, but biological 
functions of most of them are still unclear. Memczak et al., (2013) proposed a 
computational method for the detection of circRNAs in humans, mouse and C. elegans, 
and their finding suggests that circRNAs are often expressed in tissue or developmental-
stage specific manner. Guo et al., (2014) identified and quantified human circRNAs from 
ENCODE Robozero RNA-Seq data (Raney et. al., 2010), and found that most of the 
circRNAs are expressed only in few cell types. A very recent tool, called CIRI (Guo et 
al., 2014), has been proved to outperform other precedent approach for the detection of 
circRNAs from NGS data. CIRI is an annotation independent approach deploying a de 
nova algorithm for the detection of novel circRNAs based on paired chiastic clipping 
signals combined with a filtering system to eliminate false positives. 
5.4.   HiChIP Analysis 
Recently, a highly integrative pipeline, HiChIP (Yan et. al., 2014) has been developed for 
processing and systemic analysis of large amounts of ChIP-seq data. The work flow of 
this pipeline provides solutions to several challenges which has been reported for 
computational analysis of Chip-Seq/NGS data. Main functions of HiChIP are i) read 
quality checking; ii) read mapping and filtering; iii) peak calling and peak consistency 
analysis; iv) result visualizations. Moreover, this pipeline is inclusive of important 
modules for creating binding profiles over selected genomic features, de novo motif 
finding from transcription factor binding sites and functional annotation of peak 
associated genes. HiChIP is optimized to include options for filtering out less reliable 
mapped reads to reduce noise in the given experimental setup. According to the authors 
of HiChIP, several challenges still need to be addressed in the future. For instance, 
difficulties in defining the boundaries of diffuse binding sites at high resolution; 
identifying the direct target genes of transcriptional factor binding sites and histone 
modifications. It is expected that improvement in existing design and addition of new, 
better modular design of HiChIP will enable smooth integration of existing pipeline. 
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5.5.   ChIP-chip versus ChIP-seq 
ChIP followed by microarray hybridization is known as ChIP-chip, is similar in several 
aspects from recently evolved ChIP-seq. Both of these provide valuable insight to the 
protein-DNA interactions such as transcriptions factor bindings and histone 
modifications. Both ChIP-chip and ChIP-seq are widely used approaches for genome-
wide identification and characterization of in vivo protein-DNA interactions and have led 
to several important discoveries. Though having some basic similarity, the ChIP-chip had 
several limitations, which was overwhelmed by ChIP-seq. Biases present in each of these 
platforms that can arise from both the technology and analysis methods has been 
experimentally reported (Ho et. al., 2011). This research reflecting the practical 
advantages, emphasizes the ChIP-seq to be an alternate for ChIP-chip. The Table 4 
highlights the difference between these two platforms.  
 
Table 4. Difference between ChIP-chip and ChIP-seq 
S. No. ChIP-chip ChIP-seq 
1. Recent; first publication using this tech: 2007 Older; first publication using this tech: 1999 
2.  Data management id an issue (more than one Tb 
raw data is obtained usually; require huge 
storage space) 
Data management is easy (one microarray 
corresponds to  less than one Gb); require less 
storage space 
3. Data analysis require powerful computers with 
high processing power and memory (RAM) 
Computational power and memory required is 
comparatively lower 
4. High signal to noise ratios Low signal to noise ratios 
5. More peaks less peaks 
6. Multiplexing is possible Multiplexing is not possible 
6.   Software Tools 
Analysis of NGS data set is a challenging task that requires a systematic and intelligent 
approach to process it efficiently. The workflow to analyze large-scale NGS should 
include the processes: data quality assessment, comprehensive analysis, interpretation of 
results, and presentation of results in meaningful formats. There are several free as well 
as commercial software tools available for the analysis and visualization of NGS data 
sets. A list of most commonly used software tools under different task group is shown in 
Table 5. Most of the software tools cited is non-commercial, except few. 
 
Table 5.  List of NGS data analysis tools 
Task Tools URL/References 
In
te
g
ra
te
d
 T
o
o
ls
 
BaseSpace http://www.illumina.com/informatics/research/sequencing-data-
analysis-management/basespace.html 
CLC Genomics 
Workbench 
http://www.clcbio.com/products/clc-genomics-workbench/ 
ERGO http://www.igenbio.com/ergo 
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Galaxy https://wiki.galaxyproject.org/ 
Genomatix Genome 
Analyzer 
http://www.genomatix.de/solutions/genomatix-genome-
analyzer.html 
Golden Helix http://goldenhelix.com/ 
JMP Genomics http://www.jmp.com/en_us/software/jmp-genomics.html 
Lasergene Genomics 
Suite 
http://www.dnastar.com/t-products-dnastar-lasergene-
genomics.aspx 
NextGENe http://softgenetics.com/NextGENe.html 
OmicsOffice for NGS 
(SeqSolve) 
https://www.integromics.com/omicsoffice-for-ngs/ 
Partek Flow http://www.partek.com/partekflow 
SHORE http://1001genomes.org/software/shore.html 
A
li
g
n
m
en
t 
Bowtie http://bowtie-bio.sourceforge.net/ 
BFAST http://sourceforge.net/projects/bfast/ 
BWA http://bio-bwa.sourceforge.net/ 
SAMStat http://samstat.sourceforge.net/ 
Exonerate http://www.ebi.ac.uk/~guy/exonerate/ 
GenomeMapper http://1001genomes.org/ 
GMAP http://www.gene.com/share/gmap/ 
GNUMAP http://dna.cs.byu.edu/gnumap/ 
MAQ http://maq.sourceforge.net/ 
MOSAIK https://github.com/wanpinglee/MOSAIK 
MUMmer http://mummer.sourceforge.net/ 
Novoalign & 
NovoalignCS 
http://www.novocraft.com/ 
PASS http://pass.cribi.unipd.it/cgi-bin/pass.pl 
SSAHA http://www.sanger.ac.uk/Software/analysis/SSAHA/ 
SOAP http://soap.genomics.org.cn/ 
SWIFT http://bibiserv.techfak.uni-bielefeld.de/swift 
Vmatch http://www.vmatch.de/ 
ZOOM http://www.bioinfor.com/zoom/general/overview.html 
D
e 
N
o
v
a
 A
ss
e
m
b
ly
 AbySS http://www.bcgsc.ca/platform/bioinfo/software/abyss 
ALLPATHS-LG ftp://ftp.broadinstitute.org/pub/crd/ALLPATHS/Release-LG/ 
Edena http://www.genomic.ch/edena.php 
MIRA4 http://chevreux.org/projects_mira.html 
SOAPdenovo2 http://soap.genomics.org.cn/soapdenovo.html 
SSAKE http://www.bcgsc.ca/platform/bioinfo/software/ssake 
VCAKE http://sourceforge.net/projects/vcake/ 
Velvet http://www.ebi.ac.uk/~zerbino/velvet/ 
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D
is
co
v
er
y
 
GATK https://www.broadinstitute.org/gatk/ 
SAM Tools http://samtools.sourceforge.net/ 
SOAPsnp http://soap.genomics.org.cn/soapsnp.html 
ssahaSNP http://www.sanger.ac.uk/resources/software/ssahasnp/ 
PolyBayes http://clavius.bc.edu/~marth/PolyBayes/ 
PyroBayes http://bioinformatics.bc.edu/marthlab/wiki/index.php/PyroBayes 
G
en
o
m
e 
A
n
n
o
ta
ti
o
n
 
B
ro
w
se
r/
V
ie
w
er
 
Anno-J http://www.annoj.org/ 
EagleView http://www.niehs.nih.gov/research/resources/software/biostatistics/e
agleview/ 
Integrative Genomics 
Viewer 
http://www.broadinstitute.org/igv/ 
LookSeq http://www.sanger.ac.uk/resources/software/lookseq/ 
Sequence Assembly 
Manager 
http://www.bcgsc.ca/platform/bioinfo/software/sam 
Staden http://staden.sourceforge.net/ 
UCSC Genome Browser http://genome.ucsc.edu/ 
XmatchView http://www.bcgsc.ca/platform/bioinfo/software/xmatchview 
C
h
IP
-S
eq
 &
 
H
IT
S
-C
L
IP
 
A
p
p
li
ca
ti
o
n
s 
CisGenome http://www.biostat.jhsph.edu/~hji/cisgenome/ 
CNV-Seq http://tiger.dbs.nus.edu.sg/cnv-seq/ 
MACS http://liulab.dfci.harvard.edu/MACS/ 
PeakSeq http://info.gersteinlab.org/PeakSeq 
QUEST http://www-hsc.usc.edu/~valouev/QuEST/QuEST.html 
SISSRs http://dir.nhlbi.nih.gov/papers/lmi/epigenomes/sissrs/ 
T
ra
n
sc
ri
p
to
m
e 
A
n
a
ly
si
s 
E-RANGE http://woldlab.caltech.edu/rnaseq/ 
G-Mo.R-Se http://www.genoscope.cns.fr/externe/gmorse/ 
MapNext http://evolution.sysu.edu.cn/english/software/mapnext.htm 
Partek Genomic Suite http://www.partek.com/ 
RNA-Star https://github.com/alexdobin/STAR/releases 
TopHat http://ccb.jhu.edu/software/tophat 
M
et
a
g
en
o
m
ic
s 
A
n
a
ly
si
s 
MEGAN5 http://ab.inf.uni-tuebingen.de/software/megan5/ 
MOCAT http://vm-lux.embl.de/~kultima/MOCAT/ 
Parallel-META http://www.computationalbioenergy.org/parallel-meta.html 
QIIME http://qiime.org/ 
WebMGA http://weizhonglab.ucsd.edu/metagenomic-analysis 
U
ti
li
t
ie
s 
a
n
d
 FastQC http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ 
Picard http://broadinstitute.github.io/picard/ 
7.   Computational Opportunities and Challenges 
NGS has dynamically enhanced the way the researchers approached in studying the 
DNA/RNA expressions. The technological advancements like automation, parallel 
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processing, multiplexing has enabled production of low cost, high throughput data. 
Moreover, the NGS has tremendously helped in Clinical/Medical research. It is expected 
that proper understanding of the genomic variations and expressions will help in 
development of personalized medicines specific for     individuals (Soon et. al., 2013). 
Specific strategies (as in RNA-Seq) have helped in understanding the change in 
expression without the need of reference genome, which was not possible in microarray 
data analysis. Identification of vital DNA or RNA protein interaction have been made 
possible using ChIP-Seq technology which have been thought to improve our epigenetic 
studies in the days nearby (Park, 2009). It is expected, that in the coming years, ChIP-Seq 
would facilitate the epigenome-wide association studies, to identify the disease 
mechanisms in a given population (Shin et. al., 2013). Utilization of NGS techniques 
have been found useful in diagnosing clinically important genetic disorders (Zhang et al, 
2012). Sequencing of cancerous genome shall be exposing the altered/activated 
pathways, networks and other relevant information. NGS technologies not only enhanced 
our ability to detect genetic variations in non-coding region, but also helped us in 
development of enhanced statistical analysis methods in order to distinguish the true 
variations from sequencing errors (Kinde et. al., 2011). 
NGS has made it efficient for understanding the genomics, but at the same time there 
are several challenges in the way. Efficient data analysis pipelines are needed to address 
the robustness of the NGS (Morozova & Marra, 2008). Moreover, with the passage of 
time, more high-throughput assays on gene expression and DNA binding activities are 
becoming available. This in turn, raise the requirement for systems biology approaches 
for identifying and inferring associative or causal relationships between genes or proteins 
(Shin et. al., 2013). Though NGS is a powerful tool and seems to have various 
applications in clinical diagnostics, but this technology stands in complex state and its 
successful adoption into clinical laboratory would need expertise from molecular biology 
and bioinformatics (Voelkerding et. al., 2009). There is a need for computational power 
(Data processing) as well as computational management.  Storage space for huge data 
generated is also considered one of the challenges of NGS (Gullapalli et. al., 2012). 
Security of personal genomic data and ethical and political concern (for personalized 
genome data) have been addressed as possible challenges in the days nearby (Rizzo et. 
al., 2012). In addition, the cost of initial installation of NGS platforms is very much. 
Estimated start-up cost may rise over $100,000. Individual sequencing can cost over 
$1,000 per genome (Grada et. al., 2013). NGS do have false-positive and false-negative 
rates, because of sequencing errors and amplification biases (Soon et al, 2013), which 
necessitates the requirement of improved and optimized library construction methods; 
enhanced sequencing technologies and better filtering algorithms. 
The information challenge with NGS is because of its short read lengths which 
makes it difficult to assemble complete genome (Schadt et al., 2010). Most of the 
limitations are expected to be handled by third generation sequencing (TGS) technologies 
such as SMRT and nano-pore technologies. However, TGS will also have modeling, data 
management and processing challenges leading to big data problems, demanding for HPC 
such as supercomputers and computer clusters. It is expected that due to availability of 
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cloud computing based services by various companies including Amazon, Google, IBM, 
Joyent and Microsoft, the need for HPC and storage can be solved (Thakur et al., 2012). 
Further, advancement in distributed computing and availability of distributed computing 
architecture such as Hadoop (Shvachko et al., 2010) and Aneka (Vecchiola et al., 2009), 
it has become possible to handle petabyte-scale datasets distributed over a massive 
parallel architecture. Today, there are several companies offering cloud computing based 
resources for NGS and TGS data management and enable processing of large-scale raw 
sequence data. In comparison to NGS, there are more challenges for TGS due to scales 
and diversity of data it generates. 
Currently, petabyte scale of raw data is available from 1000 genome projects. The 
availability of HPC through cloud computing services, TGS is expected to allow 
scanning of entire genomes, microbiomes and transcriptome within minutes with 
affordable cost. Scanning and mining such large-scale datasets poses several challenges 
for storage, processing, analysis, data transfer, access control, integration of data, and 
standardization of data formats. 
8.   Conclusion 
The advancement of NGS technologies aided in generating genome-wide sequence data 
in a couple of days, and this huge amount of data led to numerous important discoveries. 
However, this technology needs specific data analysis algorithms which are written for 
specific task to be performed. The algorithms in group, act as a tool in analyzing the NGS 
data. Analysis of NGS data unravels important clues in quest for the treatment of various 
life-threatening diseases; improved crop varieties and other related scientific problems 
related to human welfare. This review covers basic background of NGS technologies. We 
discussed here the possible applications and computational approaches for analysis of 
various types of NGS data, including ChIP-Seq analysis, RNA-Seq analysis, Non-coding 
RNAs identification and HiChIP analysis. Importance of ChIP-Seq over ChIP-chip is 
discussed in brief. Moreover, we have also provided details of available database archives 
for NGS data and also exhaustive list of algorithms/software to perform various tasks 
during NGS data analysis. It is expected that this review covers present computational 
opportunities and also the challenges in the analysis and interpretation of NGS data. 
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